Mutual of America Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Mutual of America Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-55,463	Closed	-$2.4M	–	1216
2017 Q4	$2.4M	Buy	55,463 +2,652	+5%	+$119K	0.04%	783
2017 Q3	$2.46M	Hold	52,811	–	–	0.04%	746
2017 Q2	$2.62M	Sell	52,811 -1,847	-3%	-$96.8K	0.05%	693
2017 Q1	$3M	Sell	54,658 -1,300	-2%	-$68.8K	0.05%	605
2016 Q4	$3.12M	Sell	55,958 -289	-0.5%	-$13.9K	0.06%	551
2016 Q3	$2.57M	Hold	56,247	–	–	0.05%	608
2016 Q2	$2.25M	Hold	56,247	–	–	0.05%	639
2016 Q1	$1.96M	Sell	56,247 -400	-0.7%	-$14.7K	0.04%	677
2015 Q4	$2.43M	Buy	56,647 +337	+0.6%	+$16.9K	0.05%	554
2015 Q3	$2.45M	Hold	56,310	–	–	0.06%	538
2015 Q2	$2.91M	Hold	56,310	–	–	0.06%	486
2015 Q1	$2.21M	Sell	56,310 -1,616	-3%	-$63.3K	0.05%	670
2014 Q4	$2.24M	Buy	57,926 +904	+2%	+$34.5K	0.05%	653
2014 Q3	$2.01M	Hold	57,022	–	–	0.05%	663
2014 Q2	$1.54M	Sell	57,022 -3,440	-6%	-$89.6K	0.04%	827
2014 Q1	$1.57M	Hold	60,462	–	–	0.04%	800
2013 Q4	$1.31M	Buy	60,462 +904	+2%	+$18.5K	0.03%	865
2013 Q3	$1.16M	Buy	59,558 +1,499	+3%	+$26.6K	0.03%	865
2013 Q2	$906K	Buy	+58,059	New	+$934K	0.03%	927

Other funds holding BSTC

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mutual of America Capital Management's BSTC Position: Q1 2018 in Review

Mutual of America Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 55,463 shares — an estimated $2.4M sold.

Mutual of America Capital Management first reported a position in BSTC in Q2 2013 and held it in 19 quarters. The position peaked at $3.12M in Q4 2016. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

Mutual of America Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
Mutual of America Capital Management sold 55,463 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $2.4M.
Mutual of America Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 19 quarters.
Mutual of America Capital Management's BioSpecifics Technologies Corp. position peaked at $3.12M in Q4 2016.
78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on Mutual of America Capital Management's 13F filing for Q1 2018, filed 11 May 2018.